TipRanks
Advertisement
Advertisement

AU:1AD Stock Latest News

AdAlta advances EW-001 towards FDA engagement and Australian manufacturing
Company AnnouncementsAdAlta advances EW-001 towards FDA engagement and Australian manufacturing
14d ago
1AD
AdAlta secures Shanghai office to deepen China immunotherapy ties
PremiumCompany Announcements
AdAlta secures Shanghai office to deepen China immunotherapy ties
18d ago
1AD
AdAlta wins FDA pre‑IND meeting for lead CAR‑T cancer therapy EW‑001
PremiumCompany Announcements
AdAlta wins FDA pre‑IND meeting for lead CAR‑T cancer therapy EW‑001
26d ago
1AD
AdAlta Gains Validation as Oribiotech Wins US$120m Cell Therapy Manufacturing Deal
PremiumCompany Announcements
AdAlta Gains Validation as Oribiotech Wins US$120m Cell Therapy Manufacturing Deal
1M ago
1AD
AdAlta takes ‘East to West’ CAR-T strategy and EW-001 data to U.S. investors
PremiumCompany Announcements
AdAlta takes ‘East to West’ CAR-T strategy and EW-001 data to U.S. investors
1M ago
1AD
AdAlta gains China real-world data boost as partner’s CAR-T wins special access nod
PremiumCompany AnnouncementsAdAlta gains China real-world data boost as partner’s CAR-T wins special access nod
2M ago
1AD
AdAlta updates ASX corporate governance disclosures for 2026
Premium
Company Announcements
AdAlta updates ASX corporate governance disclosures for 2026
2M ago
1AD
AdAlta Releases Annual Report for Year Ended 30 June 2026
Premium
Company Announcements
AdAlta Releases Annual Report for Year Ended 30 June 2026
2M ago
1AD
AdAlta posts wider annual loss and flags going concern uncertainty
PremiumCompany Announcements
AdAlta posts wider annual loss and flags going concern uncertainty
2M ago
1AD
AdAlta outlines global immunotherapy ambitions while flagging investment risks
PremiumCompany Announcements
AdAlta outlines global immunotherapy ambitions while flagging investment risks
2M ago
1AD
AdAlta’s EW-001 CAR-T Shows Promising Survival and Response in Advanced Mesothelioma
PremiumCompany Announcements
AdAlta’s EW-001 CAR-T Shows Promising Survival and Response in Advanced Mesothelioma
2M ago
1AD
AdAlta Posts Landmark Long-Term Responses in Mesothelioma CAR-T Trial
PremiumCompany Announcements
AdAlta Posts Landmark Long-Term Responses in Mesothelioma CAR-T Trial
2M ago
1AD
AdAlta Advances EW-001 CAR-T Program and AI-Driven East-to-West Strategy
PremiumCompany AnnouncementsAdAlta Advances EW-001 CAR-T Program and AI-Driven East-to-West Strategy
3M ago
1AD
AdAlta Seeks ASX Quotation for Major New Share and Option Issue
Premium
Company Announcements
AdAlta Seeks ASX Quotation for Major New Share and Option Issue
4M ago
1AD
AdAlta Seeks ASX Quotation for Nearly 265 Million New Securities
Premium
Company Announcements
AdAlta Seeks ASX Quotation for Nearly 265 Million New Securities
4M ago
1AD
AdAlta expands AI-driven drug development with Oktopi collaboration
PremiumCompany Announcements
AdAlta expands AI-driven drug development with Oktopi collaboration
4M ago
1AD
AdAlta Issues 319.9 Million New Shares in Private Placement
PremiumCompany Announcements
AdAlta Issues 319.9 Million New Shares in Private Placement
4M ago
1AD
AdAlta seeks ASX quotation for major new share and option issue
PremiumCompany Announcements
AdAlta seeks ASX quotation for major new share and option issue
4M ago
1AD
AdAlta targets sophisticated investors with speculative ASX-listed options offer
PremiumCompany Announcements
AdAlta targets sophisticated investors with speculative ASX-listed options offer
5M ago
1AD
AdAlta files prospectus for options linked to A$2.5m placement to fund solid cancer immunotherapy push
PremiumCompany AnnouncementsAdAlta files prospectus for options linked to A$2.5m placement to fund solid cancer immunotherapy push
5M ago
1AD
AdAlta hires cell therapy specialists to steer FDA path for mesothelioma CAR-T
Premium
Company Announcements
AdAlta hires cell therapy specialists to steer FDA path for mesothelioma CAR-T
5M ago
1AD
AdAlta Showcases BZDS1901 CAR-T as Emerging Hope for Mesothelioma
Premium
Company Announcements
AdAlta Showcases BZDS1901 CAR-T as Emerging Hope for Mesothelioma
5M ago
1AD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >